ReviewPathologie (Heidelberg, Germany)2026
[The dysplastic nevus].
Review in Pathologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dysplastic nevus is a controversial category of melanocytic nevi. Formerly regarded as "formal histogenetic precursors of melanoma" or intermediate lesions in the progression of "common acquired nevi" to melanoma, dysplastic nevi are now considered to be benign melanocytic nevi that may simulate melanoma histopathologically. The dysplastic nevus is a very common type of melanocytic nevus. It is limited to the epidermis and papillary dermis, with the epidermal component extending beyond the dermal one; composed mostly of melanocytes with small, monomorphous nuclei; and also known as Clark's nevus. Based on an abundance of histopathologic criteria, distinction from melanoma is usually possible even in the case of some unsual findings. The term "dysplasia," originally introduced to signify diagnostic uncertainty, remains problematic because it suggests a distinct biologic quality. When employing the term "dysplastic nevus," it should be made clear whether one is referring to the common type of nevus named after Clark or whether one is trying to signify diagnostic uncertainty.
Indexed as
Identifiers
42773192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.